John Leite

Global Chief Commercial Off · Veracyte

John Leite (Global Chief Commercial Off) filed 4 Form 4 reports in the trailing twelve months (0 purchases, 4 sales), most often in Veracyte, Inc. (VCYT). The largest single filing was $700K of VCYT (13,975 sh × $50.07, as filed), executed Jun 4. Data as of Nov 8 2026.

Add to watchlist

Return, ttmiAverage return per filing, trailing twelve months

–

no purchases on file

Delay-adjustediThe same average, entered at disclosure dates

–

returns measure stock purchases only

Filings, ttm

0 buys · 4 sells

Median delay

–

measured on stock purchases

Volume, ttmiDollar value disclosed in the trailing twelve months

$1.0M

shares × price, as filed

Last traded

Sep 21

Filed Sep 22

Median ADV $55.3M across their filed names

Open performance→

Volume by month

Buys $0 Sells $1.5M

Shares × price, as filed · by filing month · past 24 months

Sectors filed on

Healthcare 4 filings

Sector per market data · by filing · past 12 months

Most traded names

VCYT

Veracyte, Inc. VCYT · 0 buys · 6 sells 6 filings

Recent filings

VCYTSALE Veracyte, Inc. View filing → $161K
4,015 sh × $40.00
Exec Sep 21
Filed Sep 22 · 5:16 PM ET VCYTSALE Veracyte, Inc. View filing → $700K
13,975 sh × $50.07
Exec Jun 4
Filed Jun 4 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $185K
5,260 sh × $35.19
Exec Mar 4
Filed Mar 6 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $140K
2,808 sh × $50.00
Exec Nov 25 2025
Filed Nov 26 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $160K
5,011 sh × $31.96
Exec Mar 7 2025
Filed Mar 10 2025 · 5:30 PM ET VCYTSALE Veracyte, Inc. View filing → $194K
5,746 sh × $33.84
Exec Feb 27 2025
Filed Mar 3 2025 · 5:30 PM ET